Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan [0.03%]
在日本非转移性去势抵抗性前列腺癌男性中恩杂鲁胺的实际使用情况
Akira Yokomizo,Junji Yonese,Shin Egawa et al.
Akira Yokomizo et al.
Background: The purpose of the study is to evaluate real-world effectiveness and safety of enzalutamide in men with nonmetastatic castration-resistant prostate cancer (nmCRPC) in Japan. ...
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer [0.03%]
妇科恶性肿瘤青春期及年轻成年患者生育力保存的现状
Tatsuru Ohara,Shiho Kuji,Tomo Takenaga et al.
Tatsuru Ohara et al.
Although the incidence of the various gynecological cancers has been increasing in recent years, long-term survival is now possible for many patients thanks to advances in multimodality treatment. When treating gynecological cancer in adole...
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy [0.03%]
日本的青少年和年轻成人癌症：流行病学与癌症战略
Kayo Nakata,Eiso Hiyama,Kota Katanoda et al.
Kayo Nakata et al.
According to national cancer registry data in Japan, approximately 20,000 adolescents and young adults (AYAs, age 15-39 years) are newly diagnosed with cancer each year. Improvements in treatment and care for AYAs with cancer are included i...
Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary? [0.03%]
对于I期卵巢透明细胞癌和完全手术分期来说，辅助紫杉烷加上铂类化疗是否需要超过三个周期？
Mayu Ukai,Shiro Suzuki,Masato Yoshihara et al.
Mayu Ukai et al.
Background: Previous studies on adjuvant chemotherapy for patients with ovarian clear cell carcinoma (OCCC) have included a limited number of Asian patients with surgical stage I OCCC, despite differences in OCCC survival...
Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis [0.03%]
真实世界回顾分析中LATITUDE高危前列腺癌日本患者的雄激素剥夺治疗，一开始就使用阿比特龙和比卡鲁胺的临床结果对比
Taku Naiki,Kiyoshi Takahara,Toshiki Ito et al.
Taku Naiki et al.
Background: Combining abiraterone (Abi) with androgen deprivation therapy (ADT) improves overall survival, compared to ADT only, in patients with metastatic castration-sensitive prostate cancer (mCSPC). In Japan, bicaluta...
Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer [0.03%]
Hsa_circ_0003195作为胃癌诊断和预后的生物标志物
Yibo Ma,Zhe Li,Dongnan Ma et al.
Yibo Ma et al.
Purpose: Recent studies have shown that circular RNAs (circRNAs) are closely related to the occurrence and development of gastric cancer. In this paper, we analyzed the value of hsa_circ_0003195 in diagnosis and prognosis...
Keywan Mortezaee,Jamal Majidpoor
Keywan Mortezaee
Evolution of tumor hallmarks is a result of accommodation of tumor cells with their nearby milieu called tumor microenvironment (TME). Accommodation or adaptive responses is highly important for a cell to survive, without which no cell is a...
Retraction Note to: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma [0.03%]
《抑制TMEM16A抑制肝细胞癌的增长并促其凋亡》的撤稿说明
Chuantao Zhang,Jianxiang Liu,Zhiyi Han et al.
Chuantao Zhang et al.
Retraction of Publication
International journal of clinical oncology. 2022 Jan;27(1):264. DOI:10.1007/s10147-021-02078-5 2022
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study [0.03%]
长期使用尼伏单抗及其后化疗治疗日本头颈癌患者的疗效：来自多中心实际研究的两年随访
Ryuji Yasumatsu,Yasushi Shimizu,Nobuhiro Hanai et al.
Ryuji Yasumatsu et al.
Background: We have previously reported the effectiveness and safety of nivolumab in patients with head and neck cancer (HNC) in real-world clinical practice in Japan. Here, we report long-term outcomes from this study in...
Observational Study
International journal of clinical oncology. 2022 Jan;27(1):95-104. DOI:10.1007/s10147-021-02047-y 2022
Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma [0.03%]
一线化疗方案的反应与转移性尿路上皮癌患者免疫检查点封锁疗法的疗效相关
Deniz Tural,Fatih Selçukbiricik,Ömer Fatih Ölmez et al.
Deniz Tural et al.
Background: Atezolizumab (ATZ) has demonstrated antitumor activity in previous studies in patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of ATZ was modest. Therefore, finding ...